Literature DB >> 26190517

Metacognitive training for schizophrenia spectrum patients: a meta-analysis on outcome studies.

B van Oosterhout1, F Smit2, L Krabbendam3, S Castelein4, A B P Staring5, M van der Gaag6.   

Abstract

BACKGROUND: Metacognitive training (MCT) for schizophrenia spectrum is widely implemented. It is timely to systematically review the literature and to conduct a meta-analysis.
METHOD: Eligible studies were selected from several sources (databases and expert suggestions). Criteria included comparative studies with a MCT condition measuring positive symptoms and/or delusions and/or data-gathering bias. Three meta-analyses were conducted on data gathering (three studies; 219 participants), delusions (seven studies; 500 participants) and positive symptoms (nine studies; 436 participants). Hedges' g is reported as the effect size of interest. Statistical power was sufficient to detect small to moderate effects.
RESULTS: All analyses yielded small non-significant effect sizes (0.26 for positive symptoms; 0.22 for delusions; 0.31 for data-gathering bias). Corrections for publication bias further reduced the effect sizes to 0.21 for positive symptoms and to 0.03 for delusions. In blinded studies, the corrected effect sizes were 0.22 for positive symptoms and 0.03 for delusions. In studies using proper intention-to-treat statistics the effect sizes were 0.10 for positive symptoms and -0.02 for delusions. The moderate to high heterogeneity in most analyses suggests that processes other than MCT alone have an impact on the results.
CONCLUSIONS: The studies so far do not support a positive effect for MCT on positive symptoms, delusions and data gathering. The methodology of most studies was poor and sensitivity analyses to control for methodological flaws reduced the effect sizes considerably. More rigorous research would be helpful in order to create enough statistical power to detect small effect sizes and to reduce heterogeneity. Limitations and strengths are discussed.

Entities:  

Keywords:  Cognitive biases; metacognitive training; psychosis; schizophrenia

Mesh:

Year:  2015        PMID: 26190517     DOI: 10.1017/S0033291715001105

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  15 in total

1.  Are Randomized Controlled Trials on Pharmacotherapy and Psychotherapy for Positive Symptoms of Schizophrenia Comparable? A Systematic Review of Patient and Study Characteristics.

Authors:  Irene Bighelli; Claudia Leucht; Maximilian Huhn; Cornelia Reitmeir; Felicitas Schwermann; Sofia Wallis; John M Davis; Stefan Leucht
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

2.  Self-reported Cognitive Biases Moderate the Associations Between Social Stress and Paranoid Ideation in a Virtual Reality Experimental Study.

Authors:  Roos Pot-Kolder; Wim Veling; Jacqueline Counotte; Mark van der Gaag
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

Review 3.  Cognitive behavioural therapy (group) for schizophrenia.

Authors:  Giuseppe Guaiana; Massimiliano Abbatecola; Ghazaleh Aali; Federica Tarantino; Ikenna D Ebuenyi; Valeria Lucarini; Wei Li; Caidi Zhang; Antonio Pinto
Journal:  Cochrane Database Syst Rev       Date:  2022-07-12

4.  Increased Belief Instability in Psychotic Disorders Predicts Treatment Response to Metacognitive Training.

Authors:  D J Hauke; V Roth; P Karvelis; R A Adams; S Moritz; S Borgwardt; A O Diaconescu; C Andreou
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

5.  Acceptance and Efficacy of Metacognitive Training (MCT) on Positive Symptoms and Delusions in Patients With Schizophrenia: A Meta-analysis Taking Into Account Important Moderators.

Authors:  Carolin Eichner; Fabrice Berna
Journal:  Schizophr Bull       Date:  2016-01-08       Impact factor: 9.306

6.  Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trial.

Authors:  Brooke C Schneider; Martin Brüne; Francesca Bohn; Ruth Veckenstedt; Katharina Kolbeck; Eva Krieger; Anna Becker; Kim Alisha Drommelschmidt; Susanne Englisch; Sarah Eisenacher; Sie-In Lee-Grimm; Matthias Nagel; Mathias Zink; Steffen Moritz
Journal:  BMC Psychiatry       Date:  2016-02-27       Impact factor: 3.630

7.  Metacognitive training in patients recovering from a first psychosis: an experience sampling study testing treatment effects.

Authors:  Karin Pos; Carin J Meijer; Oukje Verkerk; Onno Ackema; Lydia Krabbendam; Lieuwe de Haan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-21       Impact factor: 5.270

8.  Effectiveness of metacognitive interventions for mental disorders in adults: a systematic review protocol (METACOG).

Authors:  Franziska Kühne; Ramona Meister; Alessa Jansen; Martin Härter; Steffen Moritz; Levente Kriston
Journal:  BMJ Open       Date:  2017-06-22       Impact factor: 2.692

9.  SlowMo, a digital therapy targeting reasoning in paranoia, versus treatment as usual in the treatment of people who fear harm from others: study protocol for a randomised controlled trial.

Authors:  Philippa A Garety; Thomas Ward; Daniel Freeman; David Fowler; Richard Emsley; Graham Dunn; Elizabeth Kuipers; Paul Bebbington; Helen Waller; Kathryn Greenwood; Mar Rus-Calafell; Alison McGourty; Amy Hardy
Journal:  Trials       Date:  2017-11-02       Impact factor: 2.279

10.  Community-Based Psychosocial Treatment Has an Impact on Social Processing and Functional Outcome in Schizophrenia.

Authors:  Eszter Varga; Szilvia Endre; Titusz Bugya; Tamás Tényi; Róbert Herold
Journal:  Front Psychiatry       Date:  2018-06-08       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.